BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4704283)

  • 1. [Therapy of primary chronic polyarthritis using the immunosuppressive, cytostatically active podophyllin derivative, Proresid].
    Szántó L; Görgényi F; Benczur M; Reviczky A; Lörinez G; Gömör B
    Med Welt; 1973 Apr; 24(14):539-41. PubMed ID: 4704283
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our experience in the treatment of rheumatoid polyarthritis with Imuran and Proresid in outpatient units].
    Suteanu S; Dănilă E; Ionescu-Pirvu V; Rindaşu G; Ciocan A; Steflea M; Alexandru G; Ciobanu V
    Med Interna (Bucur); 1973 Dec; 25(12):1491-7. PubMed ID: 4792568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of clinical management of patients with very active rheumatoid arthritis. Comparative demonstration of therapy with non-steroid antiphlogistics, gold salts and the immunosuppressive agents proresid and endoxan].
    Wawrzyńska-Pagowska J; Graff-Wróblewska T; Juszczyk T; Michalski J; Pakula A; Piotrowska D; Scislowska M
    Z Rheumaforsch; 1973; 32(1):32-9. PubMed ID: 4693416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunosuppressive therapy of progredient chronic polyarthritis].
    Schwarze M
    MMW Munch Med Wochenschr; 1974 Feb; 116(15):341-2. PubMed ID: 4209345
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rheumatoid arthritis treated with proresid (author's transl)].
    Hunziker M; Sarkany G; Hunziker H
    Schweiz Rundsch Med Prax; 1977 Nov; 66(44):1399-401. PubMed ID: 928305
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive treatment of progressive chronic polyarthritis. Experiences with an antimitotic drug from the podophyllin series (Proresid)].
    Chlud K; Prohaska E; Zeitlhofer J; Pfaller C; Friza B
    Munch Med Wochenschr; 1968 Jan; 110(2):88-97. PubMed ID: 5695131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
    Szántó L
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:154. PubMed ID: 5402573
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the treatment of chronic polyarthritis with cytostatic agents. I. Combined therapy with trenimon and proresid. Clinical and serological studies].
    Chlud K; Prohaska E; Pfaller C
    Z Rheumaforsch; 1967 Jun; 26(5):250-60. PubMed ID: 4878333
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of primary chronic polyarthritis with immunosuppressive cytostatic podophyllin derivatives].
    Gömör B; Szántó L; Görgényi F; Benczur M; Ligetiné Reviczky A; Bányai B; Lörincz G
    Orv Hetil; 1969 Jan; 110(4):181-6. PubMed ID: 5779082
    [No Abstract]   [Full Text] [Related]  

  • 10. Proresid in the long-term treatment of rheumatoid arthritis.
    Lysholm J; Weitoft T
    Scand J Rheumatol; 1988; 17(6):465-8. PubMed ID: 3232037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problems of immunosuppressive therapy as shown on the example of chronic progressive polyarthritis].
    Jesserer H
    Z Gesamte Inn Med; 1973 Mar; 28(5):68-70. PubMed ID: 4705899
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences in the therapy of rheumatoid arthritis using isophosphamide].
    Miehlke K; Kafarnik U
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:415-8. PubMed ID: 4559449
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rheumatoid patients with Proresid.
    Lysholm J; Weitoft T
    Scand J Rheumatol; 1990; 19(2):170. PubMed ID: 2336553
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
    Szántó L
    Z Gesamte Inn Med; 1969 May; 24(10):154. PubMed ID: 5807426
    [No Abstract]   [Full Text] [Related]  

  • 15. Proresid--a valuable and well-tolerated drug?
    Larsen A
    Scand J Rheumatol; 1989; 18(4):245. PubMed ID: 2799309
    [No Abstract]   [Full Text] [Related]  

  • 16. Proresid therapy in rheumatoid arthritis. A comparison with injectable gold using life-table analysis.
    Bendix G; Bjelle A
    Scand J Rheumatol; 1993; 22(2):77-82. PubMed ID: 8480142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The P phenomenon in progressive chronic polyarthritis (pcP) and collagen diseases].
    Chlud K
    Wien Med Wochenschr; 1969 Apr; 119(17):325-7. PubMed ID: 4389131
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the treatment of chronic polyarthritis with cytostatic drugs. II. Oral application of Trenimon. Clinical and serological studies].
    Prohaska E; Chlud K; Pfaller C
    Z Rheumaforsch; 1968 Feb; 27(1):39-47. PubMed ID: 5715915
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proresid in the treatment of lung cancer].
    Gurbiel T; Juszczyński M
    Pol Tyg Lek; 1971 Sep; 26(38):1461-3. PubMed ID: 5112757
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of rheumatoid polyarthritis by so-called immunosuppressive agents].
    Bontoux D; Peltier A; Brouilhet H; Coste F
    Bull Mem Soc Med Hop Paris; 1967 May; 118(8):745-58. PubMed ID: 6060520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.